[VIVO] YoY Quarter Result on 31-Dec-2016 [#Q1]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
09-Feb-2017
Financial Year
2017
Quarter
31-Dec-2016 [#Q1]
Profit Trend
QoQ- 14.35%
YoY- -29.39%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 47,421 51,480 52,283 46,809 47,160 48,013 44,794 0.95%
PBT 4,026 10,476 7,658 9,659 13,699 12,093 11,410 -15.93%
Tax 1,199 2,370 1,356 3,380 4,806 4,192 3,984 -18.13%
NP 2,827 8,106 6,302 6,279 8,893 7,901 7,426 -14.86%
Tax Rate -29.78% -22.62% -17.71% -34.99% -35.08% -34.66% -34.92% -
Total Cost 44,594 43,374 45,981 40,530 38,267 40,112 37,368 2.98%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 5.96 15.75 12.05 13.41 18.86 16.46 16.58 -15.67%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 0.07 0.19 0.15 0.15 0.21 0.19 0.18 -14.55%
EPS Diluted 0.07 0.19 0.15 0.15 0.21 0.19 0.18 -14.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.